COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,220 Articles (22,733 medRxiv, 8,487 bioRxiv)

Most recent first Previous |  Page 423: Articles 4221-4230  | Next

Emergency department visits and boarding for pediatric patients with suicidality before and during the COVID-19 pandemic
Zipursky, A. R., Olsen, K. L., Bode, L., Geva, A., Jones, J., Mandl, K. D., McMurry, A.
10.1101/2023.05.08.23289659 — Posted: 2023-05-08
Mobilizing faith-based COVID-19 health ambassadors to address COVID-19 health disparities among African American older adults in under-resourced communities: A hybrid, community-based participatory intervention
Adinkrah, E., Cobb, S., Bazargan, S., Kibe, L. W., Vargas, R., Waller, J., Sanchez, H., Bazargan, M.
10.1101/2023.05.07.23289636 — Posted: 2023-05-08
Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
Shi, G., Li, T., Lai, K. K., Yewdell, J., Compton, A.
10.1101/2023.05.06.539698 — Posted: 2023-05-08
Dimeric Transmembrane Structure of the SARS-CoV-2 E Protein
Zhang, R., Qin, H., Prasad, R., Fu, R., Zhou, H.-X., Cross, T. A.
10.1101/2023.05.07.539752 — Posted: 2023-05-08
Robust identification of perturbed cell types in single-cell RNA-seq data
Nicol, P. B., Paulson, D., Qian, G., Liu, X. S., Irizarry, R. A., Sahu, A. D.
10.1101/2023.05.06.539326 — Posted: 2023-05-08
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
Pandey, B., Wang, Z., Jimenez, A., Bhatia, E., Jain, R., Beach, A., Maniar, D., Hosten, J., O'Farrell, L., Vantucci, C., Hur, D., Noel, R. K., Ringquist, R. M., Smith, C., Ochoa, M. A., Roy, K.
10.1101/2023.05.05.539395 — Posted: 2023-05-08
SARS-COV-2 Spike Protein Fragment eases Amyloidogenesis of α-Synuclein
Hansmann, U. H. E., Maiti, B., Chesney, A. D.
10.1101/2023.05.06.539715 — Posted: 2023-05-08
Host inducible-HSP70A1A is an irresistible drug target to combat SARS-CoV-2 infection and pathogenesis
Joshi, P., Garg, S., Mani, S., Jakhar, K., Marothia, M., Shoaib, R., Biswas, S., Singhal, J., Behl, A., Kahlon, A. K., Shevtsov, M., Garg, P., Singh, S., Ranganathan, A.
10.1101/2023.05.05.539661 — Posted: 2023-05-08
The Coviral Portal: Multi-Cohort Viral Loads and Antigen-Test Virtual Trials for COVID-19
Morgan, A., Contreras, E., Yasuda, M., Dutta, S., Hamel, D. J., Shankar, T., Balallo, D., Riedel, S., Kirby, J. E., Kanki, P. J., Arnaout, R.
10.1101/2023.05.05.23289582 — Posted: 2023-05-07
Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19
Milross, L., Hunter, B., McDonald, D., Merces, G., Thompson, A., Hilkens, C. M. U., Wills, J., Rees, P., Jiwa, K., Cooper, N., Majo, J., Ashwin, H., Duncan, C. J. A., Kaye, P. M., Bayraktar, O. A., Filby, A., Fisher, A. J.
10.1101/2023.05.05.23289594 — Posted: 2023-05-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).